Letter
Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry
H.F. Mann1, J. Závada2, L. Šenolt3, K. Bubová4, L. Nekvindová5, Z. Křístková6, P. Horák7, J. Vencovský8, K. Pavelka9
- Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. mann@revma.cz
- Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Biostatistics and Analyses, Ltd., spinoff company of Masaryk University, Brno, Czech Republic.
- Institute of Biostatistics and Analyses, Ltd., spinoff company of Masaryk University, Brno, Czech Republic.
- IIIrd Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
and the ATTRA Registry
CER11633
2019 Vol.37, N°2
PI 0342, PF 0343
Letter
Free to view
(click on article PDF icon to read the article)
PMID: 30620295 [PubMed]
Received: 20/08/2018
Accepted : 09/10/2018
In Press: 04/01/2019
Published: 19/03/2019